Kiyoshi Negayama
- Endocrinology top 5%
- Epidemiology
- Molecular Biology
- Infectious Diseases
- Pulmonary and Respiratory Medicine
- Co-authors
- Jiro FujitaSatoko HojoJ TakaharaKeiichi TakigawaJiro TakaharaHiroyuki MiyawakiYasuyuki YamajiYasufumi Yamaji
- Topics
- Mycobacterium research and diagnosis (7 papers)Bacterial biofilms and quorum sensing (5 papers)Antibiotic Use and Resistance (4 papers)
- Journals
- CHEST JournalJournal of the American Academy of DermatologyJournal of Antimicrobial Chemotherapy
- Partner nations
- Japan
In The Last Decade
Kiyoshi Negayama
28 papers receiving 326 citations
Peers
Comparison fields: 5 of 72
- Endocrinology 95
- Epidemiology 92
- Molecular Biology 84
- Infectious Diseases 75
- Pulmonary and Respiratory Medicine 63
Countries citing papers authored by Kiyoshi Negayama
This map shows the geographic impact of Kiyoshi Negayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Negayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Negayama more than expected).
Fields of papers citing papers by Kiyoshi Negayama
This network shows the impact of papers produced by Kiyoshi Negayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Negayama. The network helps show where Kiyoshi Negayama may publish in the future.
Co-authorship network of co-authors of Kiyoshi Negayama
This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Negayama. A scholar is included among the top collaborators of Kiyoshi Negayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Negayama. Kiyoshi Negayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 6 | |
| 4 | 12 | |
| 5 | 22 | |
| 6 | 5 | |
| 7 | 65 | |
| 8 | 5 | |
| 9 | 4 | |
| 10 | 0 | |
| 11 | Neutrophil migration into the mucous layer in Helicobacter pylori-associated gastritis | 5 |
| 12 | 30 | |
| 13 | 29 | |
| 14 | 1 | |
| 15 | 4 | |
| 16 | 4 | |
| 17 | 1 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 13 |
About Kiyoshi Negayama
Kiyoshi Negayama is a scholar working on Applied Microbiology and Biotechnology, Microbiology and Endocrinology, having authored 30 papers that have together received 343 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (7 papers), Bacterial biofilms and quorum sensing (5 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Microbiology (15 citations), Endocrinology (95 citations) and Molecular Medicine (48 citations). Kiyoshi Negayama has collaborated with scholars based in Japan. Frequent co-authors include Jiro Fujita, Satoko Hojo, J Takahara, Keiichi Takigawa, Jiro Takahara, Hiroyuki Miyawaki, Yasuyuki Yamaji, Yasufumi Yamaji, Guimin Xu and K Kawanishi. Their work appears in journals such as CHEST Journal, Journal of the American Academy of Dermatology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.